Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Uterine Natural Killer (uNK) Cell Expression in Patients With Repeated ICSI Failures: A Multicenter Cohort Study

NCT04867759 is registered in ClinicalTrials.gov with Tanta University as lead sponsor.

NCT NCT04867759
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04867759 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Uterine Natural Killer (uNK) Cell Expression in Patients With Repeated ICSI Failures: A Multicenter Cohort Study
Lead sponsor
Tanta University
Phase
Observational
Overall status
Unknown status
Start date
May 1, 2021
Completion date
December 1, 2024
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

icsi failure, repeated implantation failure, unatural killer cells